Dose-Dense Adjuvant Doxorubicin and Cyclophosphamide Is Not Associated With Frequent Short-Term Changes in Left Ventricular Ejection Fraction

PURPOSE: Doxorubicin and cyclophosphamide (AC) every 3 weeks has been associated with frequent asymptomatic declines in left ventricular ejection fraction (LVEF). Dose-dense (dd) AC followed by paclitaxel (P) is superior to the same regimen given every third week. Herein, we report the early cardiac...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Morris, Patrick G., Dickler, Maura, McArthur, Heather L., Traina, Tiffany, Sugarman, Steven, Lin, Nancy, Moy, Beverly, Come, Steven, Godfrey, Laura, Nulsen, Benjamin, Chen, Carol, Steingart, Richard, Rugo, Hope, Norton, Larry, Winer, Eric, Hudis, Clifford A., Dang, Chau T.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2009
נושאים:
Original Reports
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3664032/
https://ncbi.nlm.nih.gov/pubmed/19901120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.2952
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים